Cite
HARVARD Citation
Buti, M. et al. (2016). Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet gastroenterology and hepatology. pp. 196-206. [Online].